Assessment of the treatment effectiveness of men with mild and medium degree of erectile dysfunction.

Autor: Trishch VI; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Mysak AI; I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE., Trishch AI; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Mandzii AP; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.

Publikováno v: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2024; Vol. 52 (1), pp. 79-86.

Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients.

Autor: Sokmen, Dogukan¹, Comez, Yusuf Ilker² icomez@hotmail.com

Publikováno v: Aging Male. Dec2023, Vol. 26 Issue 1, p1-6. 6p.

Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta-analyses.

Autor: Labetov I; Neurourology department, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia., Vaganova A; Neurourology department, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia.; Institute of Translational Biomedicine, Saint-Petersburg State University, Saint-Petersburg, Russia., Kovalev G; Neurourology department, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia., Shkarupa D; Neurourology department, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia.

Publikováno v: Neurourology and urodynamics [Neurourol Urodyn] 2024 Nov; Vol. 43 (8), pp. 1924-1937. Date of Electronic Publication: 2024 Jun 07.

The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.

Autor: Kong X; Research Institute of Urology / Key Laboratory of Gansu Province for Urological Diseases / Clinical Center of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou City, Gansu Province, China., Hu W; Department of Nephrology, The Second Hospital of Lanzhou University, Lanzhou City, Gansu Province, China., Dong Z; Research Institute of Urology / Key Laboratory of Gansu Province for Urological Diseases / Clinical Center of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou City, Gansu Province, China., Tian J; Research Institute of Urology / Key Laboratory of Gansu Province for Urological Diseases / Clinical Center of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou City, Gansu Province, China., Wang Y; Research Institute of Urology / Key Laboratory of Gansu Province for Urological Diseases / Clinical Center of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou City, Gansu Province, China., Jin C; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Liang C; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Hao Z; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Wang Z; Research Institute of Urology / Key Laboratory of Gansu Province for Urological Diseases / Clinical Center of Gansu Province for Urological Diseases, Lanzhou University Second Hospital, Lanzhou City, Gansu Province, China. wangzplzu@163.com.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Sep; Vol. 26 (3), pp. 483-494. Date of Electronic Publication: 2022 Jul 07.